Increased cardiovascular risk in South African patients with addison's disease

Hormone and Metabolic Research

Volumn 45, Issue 12, 2013, Pages 905-910

  Ross, I L ^a   Bergthorsdottir, R ^b   Levitt, N S ^a   Schatz, D A ^c   Johannsson, G ^b   Marais, A D ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

atherosclerosis risk; lipids; lipoproteins; primary hypoadrenalism

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN; CORTISONE ACETATE; DEXAMETHASONE; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; STEROID 21 MONOOXYGENASE; TRIACYLGLYCEROL;

ADDISON DISEASE; ADULT; ARTICLE; BODY MASS; BODY SURFACE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AFRICA; TRIACYLGLYCEROL BLOOD LEVEL;

ADDISON DISEASE; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DEMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; SOUTH AFRICA;

EID: 84887844197     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351259     Document Type: Article

References (43)

1. Arlt W., Allolio B. Adrenal insufficiency. Lancet: 2003; 361 1881 1893 (Pubitemid 36645187)
2. Erichsen M. M., Lovas K., Fougner K. J., Svartberg J., Hauge E. R., Bollerslev J., Berg J. P., Mella B., Husebye E. S. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol: 2009; 160 233 237
3. Bergthorsdottir R., Leonsson-Zachrisson M., Oden A., Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab: 2006; 91 4849 4853 (Pubitemid 44917317)
4. Sholter D. E., Armstrong P. W. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol: 2000; 16 505 511 (Pubitemid 30245588)
5. Reaven E. P., Kolterman O. G., Reaven G. M. Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles. J Lipid Res: 1974; 15 74 83
6. Hazra A., Pyszczynski N. A., DuBois D. C., Almon R. R., Jusko W. J. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res: 2008; 25 769 780 (Pubitemid 351661827)
7. Faggiano A., Pivonello R., Spiezia S., De Martino M. C., Filippella M., Di Somma C., Lombardi G., Colao A. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab: 2003; 88 2527 2533 (Pubitemid 36724418)
8. Danilowicz K., Bruno O. D., Manavela M., Gomez R. M., Barkan A. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary: 2008; 11 279 285
9. Ettinger W. H. Jr, Hazzard W. R. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism: 1988; 37 1055 1058
10. Bagdade J. D., Yee E., Albers J., Pykalisto O. J. Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism: 1976; 25 533 542
11. Nanjee M. N., Miller N. E. Plasma lipoproteins and adrenocortical hormones in men - positive association of low density lipoprotein cholesterol with plasma cortisol concentration. Clin Chim Acta: 1989; 180 113 120 (Pubitemid 19071371)
12. Giordano R., Marzotti S., Balbo M., Romagnoli S., Marinazzo E., Berardelli R., Migliaretti G., Benso A., Falorni A., Ghigo E., Arvat E. Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement. J Endocrinol Invest: 2009; 32 917 923
13. Gurnell E. M., Hunt P. J., Curran S. E., Conway C. L., Pullenayegum E. M., Huppert F. A., Compston J. E., Herbert J., Chatterjee V. K. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab: 2008; 93 400 409 (Pubitemid 351240809)
14. Norman R., Bradshaw D., Schneider M., Jewkes R., Mathews S., Abrahams N., Matzopoulos R., Vos T. Estimating the burden of disease attributable to interpersonal violence in South Africa in 2000. S Afr Med J: 2007; 97 653 656
15. Steyn K., Levitt N. S., Hoffman M., Marais A. D., Fourie J. M., Lambert E. V., Gaziano T. A., Kepe L., Lombard C. J. The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study. Ethn Dis: 2004; 14 233 242 (Pubitemid 39302865)
16. Steyn K., Steyn M., Swanepoel A. S., Jordaan P. C., Jooste P. L., Fourie J. M., Rossouw J. E. Twelve-year results of the Coronary Risk Factor Study (CORIS). Int J Epidemiol: 1997; 26 964 971 (Pubitemid 27478511)
17. Oelofse A., Jooste P. L., Steyn K., Badenhorst C. J., Lombard C., Bourne L., Fourie J. The lipid and lipoprotein profile of the urban black South Africa population of the Cape Peninsula - the BRISK study. S Afr Med J: 1996; 86 162 166 (Pubitemid 26098389)
18. Steyn K., Rossouw J. E., Joubert G. The coexistence of major coronary heart disease risk factors in the coloured population of the Cape Peninsula (CRISIC study). S Afr Med J: 1990; 78 61 63 (Pubitemid 20262338)
19. Reddy K. S., Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation: 1998; 97 596 601 (Pubitemid 28090690)
20. Ross I., Boulle A., Soule S., Levitt N., Pirie F., Karlsson A., Mienie J., Yang P., Wang H., She J. X., Winter W., Schatz D. Autoimmunity predominates in a large South African cohort with Addison's disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201. Clin Endocrinol (Oxf): 2010; 73 291 298
21. Soule S. Addison's disease in Africa - a teaching hospital experience. Clin Endocrinol (Oxf): 1999; 50 115 120 (Pubitemid 29079376)
22. Wilson P. W., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B. Prediction of coronary heart disease using risk factor categories. Circulation: 1998; 97 1837 1847 (Pubitemid 28213628)
23. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem: 1972; 18 499 502
24. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA: 2001; 285 2486 2497
25. Gidez L. I., Miller G. J., Burstein M., Slagle S., Eder H. A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res: 1982; 23 1206 1223 (Pubitemid 13187618)
26. Blom D. J., Byrnes P., Jones S., Marais A. D. Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia. J Lipid Res: 2003; 44 212 217 (Pubitemid 36114787)
27. Klug ER F., Marais A. D., Taskinen M-R, Dalby A. J., Schamroth C., Rapeport N., Jankelow D., Blom D. J., Catsicas R., Webb D. A. South African dyslipidaemia guideline consensus statement. S Afr Med J: 2012; 102 178 187
28. van der Westhuyzen D. R., de Beer F. C., Webb N. R. HDL cholesterol transport during inflammation. Curr Opin Lipidol: 2007; 18 147 151 (Pubitemid 46412084)
29. Beentjes J. A., van Tol A., Sluiter W. J., Dullaart R. P. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy. Scand J Clin Lab Invest: 2000; 60 189 198 (Pubitemid 30399104)
30. Garcia-Gomez C., Nolla J. M., Valverde J., Narvaez J., Corbella E., Pinto X. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest: 2008; 38 686 692
31. Staels B., van Tol A., Chan L., Verhoeven G., Auwerx J. Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb: 1991; 11 760 769
32. Lin R. C. Effects of hormones on apolipoprotein secretion in cultured rat hepatocytes. Metabolism: 1988; 37 745 751
33. Brotman D. J., Girod J. P., Garcia M. J., Patel J. V., Gupta M., Posch A., Saunders S., Lip G. Y., Worley S., Reddy S. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab: 2005; 90 3202 3208 (Pubitemid 41014276)
34. Atger V., Leclerc T., Cambillau M., Guillemain R., Marti C., Moatti N., Girard A. Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity. Atherosclerosis: 1993; 103 29 41 (Pubitemid 23313137)
35. Berg A. L., Nilsson-Ehle P. Direct effects of corticotropin on plasma lipoprotein metabolism in man - studies in vivo and in vitro. Metabolism: 1994; 43 90 97 (Pubitemid 24047110)
36. Bjornheden T., Babyi A., Bondjers G., Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis: 1996; 123 43 56 (Pubitemid 26175068)
37. Monteiro C. M., Pinheiro L. F., Izar M. C., Barros S. W., Vasco M. B., Fischer S. M., Povoa R. M., Brandao S. A., Santos A. O., Oliveira L., Carvalho A. C., Fonseca F. A. Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event. Braz J Med Biol Res: 2010; 43 297 302
38. Rice SP L., Agarwal N., Bolusani H., Newcombe R., Scanlon M. F., Ludgate M., Rees D. A. Effects of Dehydroepiandrosterone Replacement on Vascular Function in Primary and Secondary Adrenal Insufficiency: A Randomized Crossover Trial. J Clin Endocrinol Metabol: 2009; 94 1966 1972
39. Carlsson M., Wessman Y., Almgren P., Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol: 2000; 20 1588 1594 (Pubitemid 30353892)
40. Straznicky N. E., Eikelis N., Lambert E. A., Esler M. D. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep: 2008; 10 440 447
41. Early J. Comprehensive management of cardiometabolic risk factors. Clin Cornerstone: 2007; 8 69 80 (Pubitemid 351597785)
42. Hafstrom I., Rohani M., Deneberg S., Wornert M., Jogestrand T., Frostegard J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study. J Rheumatol: 2007; 34 1810 1816 (Pubitemid 350067638)
43. The metabolic and molecular basis of inherited disease. New York McGraw-Hill: 2001